The Indian government is set to limit open market access to key anti-tuberculosis medicines in order to contain misuse of critical medications that could lead to the emergence of drug resistance. This measure comes in light of the expiry of...
Hyderabad-based Bharat Biotech and multinational pharmaceutical Corporation GlaxoSmithKline (GSK) have reached an agreement to make the world-first malaria vaccine, Mosquirix (RTS,S), affordable and more readily available to citizens of malar...
According to Telix Pharmaceuticals Limited, a biopharmaceutical company based in Melbourne that specializes in the development and marketing of therapeutic and diagnostic radiopharmaceuticals as well as related medical technologies
India's MedTech ecosystem is getting a massive boost through the Production Linked Incentive (PLI) scheme for medical devices. For Falgun Jani, Business Head, Freudenberg Medical India, the policy thrust towards high-end diagnostic
When comparing the tolerability, safety, and effectiveness of atogepant to the highest tolerated dose of topiramate in adult patients with a history of four or more migraine days per month.
The Discovery Park Startup Showcase took centre stage at the London Biotechnology Show 2025, sparking dynamic conversations and real-time feedback between emerging biotech entrepreneurs and seasoned investors.
Welcure Drugs & Pharmaceuticals announced on Wednesday that it has finalized a contract with Thailand-based Fortune Sagar Impex Compamy for third-party sourcing and procurement services totaling Rs 517 cr
Boehringer Ingelheim, a global leader in animal health, has announced the launch of its latest poultry vaccine in India—a single-dose, next-generation solution that provides protection against Bursal, Newcastle and Marek’s disease...
In a significant step toward strengthening India’s pharmaceutical and trade export ecosystem, the Directorate General of Foreign Trade (DGFT), Ministry of Commerce and Industry, has announced the launch of the ‘Source from India’ feature...
The Department of Pharmaceuticals (DoP) has clarified that they extended the application period for the most recent PLI scheme round for bulk drugs, from June 14 to July 4, 2025...
.jpg)
.jpg)
, CDSCO.jpg)